Search Results - "Talasaz, AmirAli"
-
1
Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies
Published in Clinical cancer research (01-08-2018)“…To analytically and clinically validate a circulating cell-free tumor DNA sequencing test for comprehensive tumor genotyping and demonstrate its clinical…”
Get full text
Journal Article -
2
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Published in Clinical cancer research (01-08-2018)“…Cell-free DNA (cfDNA) sequencing provides a noninvasive method for obtaining actionable genomic information to guide personalized cancer treatment, but the…”
Get full text
Journal Article -
3
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Published in Nature medicine (01-09-2018)“…Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the…”
Get full text
Journal Article -
4
mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer
Published in PloS one (07-11-2012)“…Circulating tumor cells (CTC) mediate metastatic spread of many solid tumors and enumeration of CTCs is currently used as a prognostic indicator of survival in…”
Get full text
Journal Article -
5
Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing
Published in Cancer research (Chicago, Ill.) (01-10-2017)“…Noninvasive genomic profiling of tumors may be possible with next-generation sequencing (NGS) of blood-derived circulating tumor DNA (ctDNA), but proof of…”
Get full text
Journal Article -
6
Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma
Published in Clinical cancer research (01-09-2017)“…Genomic alterations in blood-derived circulating tumor DNA (ctDNA) from patients with non-small cell lung adenocarcinoma (NSCLC) were ascertained and…”
Get full text
Journal Article -
7
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non–small cell lung cancer: Analysis of over 8000 cases
Published in Cancer (15-07-2020)“…Background Circulating cell‐free tumor DNA (ctDNA)‐based mutation profiling, if sufficiently sensitive and comprehensive, can efficiently identify genomic…”
Get full text
Journal Article -
8
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Published in Clinical cancer research (01-12-2019)“…To analytically and clinically validate microsatellite instability (MSI) detection using cell-free DNA (cfDNA) sequencing. Pan-cancer MSI detection using…”
Get full text
Journal Article -
9
Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines
Published in PloS one (07-05-2012)“…To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with…”
Get full text
Journal Article -
10
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Published in PloS one (16-10-2015)“…Next-generation sequencing of cell-free circulating solid tumor DNA addresses two challenges in contemporary cancer care. First this method of massively…”
Get full text
Journal Article -
11
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
Published in Proceedings of the National Academy of Sciences - PNAS (10-03-2009)“…The enumeration of rare circulating epithelial cells (CEpCs) in the peripheral blood of metastatic cancer patients has shown promise for improved cancer…”
Get full text
Journal Article -
12
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Published in Cancer discovery (01-10-2015)“…Patients with pancreatic and biliary carcinomas lack personalized treatment options, in part because biopsies are often inadequate for molecular…”
Get more information
Journal Article -
13
S295 Implementation of Blood-Based Colorectal Cancer Screening: Real-World Clinical Experience
Published in The American journal of gastroenterology (01-10-2023)Get full text
Journal Article -
14
-
15
Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
Published in The oncologist (Dayton, Ohio) (01-05-2018)“…Background Because imaging has a high sensitivity to diagnose hepatocellular carcinoma (HCC) and tissue biopsies carry risks such as bleeding, the latter are…”
Get full text
Journal Article -
16
-
17
-
18
-
19
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay
Published in Oncotarget (01-03-2016)“…Analysis of cell-free DNA using next-generation sequencing (NGS) is a powerful tool for the detection/monitoring of alterations present in circulating tumor…”
Get full text
Journal Article -
20
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Published in Clinical cancer research (15-10-2019)“…Molecular profiling has been used to select patients for targeted therapy and determine prognosis. Noninvasive strategies are critical to hepatocellular…”
Get full text
Journal Article